Abstract
Purpose
Hearing loss and tinnitus are prevalent among survivors of head and neck cancer (HNC), but auditory issues are under-addressed in the survivorship literature. The purpose of this study was to describe the hearing loss and management experience of a group of survivors provided with a hearing screening and amplifier assistance if needed during their visit.
Methods
A retrospective chart review of 1176 individuals seen in the HNC Survivorship Clinic between December 2016 and October 2020 who interacted with audiology was performed.
Results
Of these survivors, 72% failed the 30-dB HL hearing screening at one or more frequencies. Thirty-three percent of the sample reported tinnitus. Consistent with the general population, this group has a low prevalence of hearing aid use. In this clinic, individuals who fail the hearing screening at all frequencies are offered a simple, non-custom amplifier for use during their visit. Thirty-one percent of individuals offered the amplifier used it during their Survivorship Clinic visit to enhance communication and reduce listening effort. Only 54% of individuals who failed the hearing screening self-reported hearing loss. The poor sensitivity and specificity associated with the self-perception of hearing loss data support the need for hearing screening that consists of responding to tones. Of individuals who received a recommendation for a comprehensive hearing test, 21% received a hearing test with 68% of these individuals receiving the hearing test the same day of their Survivorship Clinic visit.
Conclusions
The data from 1176 survivors of HNC seen by audiology over the past few years as part of the UPMC HNC Survivorship Clinic support the need for hearing management in this population to improve communication during and after the Survivorship Clinic visit.
Implications for Cancer Survivors
Survivors of HNC have a high prevalence of greater than mild hearing loss and tinnitus (both issues known to negatively impact health-related communication and quality of life). This manuscript describes a hearing screening program within a Survivorship Clinic that identifies individuals in need of non-custom amplification during their appointment to support effective communication. Survivors should be referred to audiologists for evaluation and management of treatment-related issues of hearing.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
N/A.
References
Nilsen ML, Mady LJ, Hodges J, Wasserman-Wincko T, Johnson JT. Burden of treatment: reported outcomes in a head and neck cancer survivorship clinic. Laryngoscope. 2019;129(12):E437–44. https://doi.org/10.1002/lary.27801.
Mujica-Mota M, Waissbluth S, Daniel SJ. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review. Head Neck. 2013;35(11):1662–8. https://doi.org/10.1002/hed.23201.
Theunissen EAR, Zuur C, Bosma S, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer J, van der Molen L, Rasch CRN, Dreschler W, Balm A. Long-term hearing loss after chemoradiation in patients with head and neck cancer. Laryngoscope. 2014;124(12):2720–5. https://doi.org/10.1002/lary.24802.
Chaibakhsh S, Zayeri F, Baghestani AR, Bakhshandeh M, Aghamiri SMR, Safari AH. The effect of radiation therapy on hearing loss in patients with head and neck cancer. Int J Cancer Manag. 2018;11(4): e10421. https://doi.org/10.5812/ijcm.10421.
Schmitt NC, Page BR. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients. Int J Audiol. 2018;57(S4):S49-54. https://doi.org/10.1080/14992027.2017.1353710.
Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712–20. https://doi.org/10.1200/JCO.2016.66.8822.
Schaefer SD, Post JD, Close LG, Wright CG. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 1985;56(8):1934–9. https://doi.org/10.1002/1097-0142(19851015)56:8%3C1934::AID-CNCR2820560807%3E3.0.CO;2-F.
Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P. Cisplatin ototoxicity: the importance of baseline audiometry. Am J Clin Oncol. 1999;22(3):305–8.
Cohen EEW, LaMonte S, Erb N, Beckman K, Sadeghi N, Hutcheson K, Stubblefield M, Abbott D, Fisher P, Stein K, Lyman G, Pratt-Chapman M. American Cancer Society head and neck cancer survivorship care guideline. Cancer J Clin. 2016;66(3):203–39. https://doi.org/10.3322/caac.21343.
Campbell KCM, Le Prell CG. Drug-induced ototoxicity: diagnosis and monitoring. drug safety. 2018;41(5):451–64. https://doi.org/10.1007/s40264-017-0629-8
Cudmore V, Henn P, O’Tuathaigh CMP, Smith S. Age-related hearing loss and communication breakdown in the clinical setting. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1054–5. https://doi.org/10.1001/jamaoto.2017.1248.
Henn P, O’Tuathaigh C, Keegan D, Smith S. Hearing impairment and the amelioration of avoidable medical error. J Patient Saf. 2021;17(3):e155-160. https://doi.org/10.1097/PTS.0000000000000298.
Stevens MN, Dubno JR, Wallhagen MI, Tucci DL. Communication and healthcare: self-reports of people with hearing loss in primary care settings. Clin Gerontol. 2019;42(5):485–94. https://doi.org/10.1080/07317115.2018.1453908.
Mick P, Foley D, Lin F, Pichora-Fuller MK. Hearing difficulty is associated with injuries requiring medical care. Ear Hear. 2018;39(4):631–44. https://doi.org/10.1097/AUD.0000000000000535.
Reed NS, Altan A, Deal J, Yeh C, Kravetz A, Wallhagen M, Lin F. Trends in health care costs and utilization associated with untreated hearing loss over 10 years. JAMA Otolaryngol Head Neck Surg. 2019;145(1):27–34. https://doi.org/10.1001/jamaoto.2018.2875.
Hoffman JM, Yorkston KM, Shumway-Cook A, Ciol MA, Dudgeon BJ, Chan L. Effect of communication disability on satisfaction with health care: a survey of medicare beneficiaries. Am J Speech-Language Pathol. 2005;14(3):221–8. https://doi.org/10.1044/1058-0360(2005/022).
Bartlett G, Blais R, Tamblyn R, Clermont RJ, MacGibbon B. Impact of patient communication problems on the risk of preventable adverse events in acute care settings. Can Med Assoc J. 2008;178(12):1555–62. https://doi.org/10.1503/cmaj.070690.
Genther DJ, Betz J, Pratt S, Martin K, Harris T, Satterfield S, Bauer DC, Newman AB, Simonsick EM, Lin FR. Association between hearing impairment and risk of hospitalization in older adults. J Am Geriatr Soc. 2015;63(6):1146–52. https://doi.org/10.1111/jgs.13456.
Hsu AK, McKee M, Williams S, Roscigno C, Crandell J, Lewis A, Hazzard W, Jenerette C. Associations among hearing loss, hospitalization, readmission and mortality in older adults: a systematic review. Geriatr Nurs. 2019;40(4):367–79. https://doi.org/10.1016/j.gerinurse.2018.12.013.
Chang JE, Weinstein B, Chodosh J, Blustein J. Hospital readmission risk for patients with self-reported hearing loss and communication trouble. J Am Geriatr Soc. 2018;66(11):2227–8. https://doi.org/10.1111/jgs.15545.
Davidson JG, Guthrie DM. Older adults with a combination of vision and hearing impairment experience higher rates of cognitive impairment, functional dependence, and worse outcomes across a set of quality indicators. J Aging Health. 2019;31(1):85–108. https://doi.org/10.1177/0898264317723407.
Mener DJ, Betz J, Genther DJ, Chen D, Lin FR. Hearing loss and depression in older adults. J Am Geriatr Soc. 2013;61(9):1627–9. https://doi.org/10.1111/jgs.12429.
Gregory S, Billings J, Wilson D, Livingston G, Schilder AG, Costafreda SG. Experiences of hearing aid use among patients with mild cognitive impairment and Alzheimer’s disease dementia: a qualitative study. SAGE Open Med. 2020;8:1–9. https://doi.org/10.1177/2050312120904572.
Mamo SK, Nirmalasari O, Nieman C, McNabney M, Simpson A, Oh E, Lin FR. Hearing care intervention for persons with dementia: a pilot study. Am J Geriatr Psychiatry. 2017;25(1):91–101. https://doi.org/10.1016/j.jagp.2016.08.019.
Douglas H, Georgiou A, Westbrook J. Social participation as an indicator of successful aging: an overview of concepts and their associations with health. Aust Health Rev. 2017;41(4):455–62. https://doi.org/10.1071/AH16038.
Chien W, Lin FR. Prevalence of hearing aid use among older adults in the United States. Arch Intern Med. 2012;172(3):2923. https://doi.org/10.1001/archinternmed.2011.1408.
Jorgensen L, Novak M. Factors influencing hearing aid adoption. Semin Hear. 2020;41(1):6–20. https://doi.org/10.1055/s-0040-1701242.
Kimball AR, Roscigno CI, Jenerette CM, Hughart KM, Jenkins WW, Hsu W. Amplified hearing device use in acute care settings for patients with hearing loss: a feasibility study. Geriatr Nurs. 2018;39(3):279–84. https://doi.org/10.1016/j.gerinurse.2017.10.009.
Zitelli L, Palmer CV. The effect of outpatient interventional audiology on inpatient audiology services. Semin Hear. 2017;38(2):160–8. https://doi.org/10.1055/s-0037-1601571.
Ringash J, McQuestion M. Designing a survivorship program for head and neck cancer patients. J Clin Oncol. 2013;31(15S):e17007.
Funk GF, Pasker KL, Bayon R, Pagedar NA, Karnell LH. Head-and-neck cancer survivorship clinic satisfaction study. Int J Radiat Oncol. 2014;88(2):528. https://doi.org/10.1016/j.ijrobp.2013.11.199.
Harr BA, Bodmann JW, Koyfman SA, Nwizu TI, Greskovich JF, Hamker JJ, Ives DI, Rahe ML, Adelstein DJ. Development of a head-and-neck cancer survivorship clinic: the Cleveland clinic experience. Int J Radiat Oncol. 2014;88(2):525–6. https://doi.org/10.1016/j.ijrobp.2013.11.192.
Hessel AC, Beadle BM, Burke LE. Continuity of care: process improvement for a multidisciplinary head-and-neck cancer clinic. Int J Radiat Oncol. 2014;88(2):531. https://doi.org/10.1016/j.ijrobp.2013.11.221.
Salz T, McCab M, Oeffinger K, Corcoran S, Vickers A, Salner A, Dornelas E, Schnall R, Raghunathan N, Fortier E, Baxi S. A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study. Pilot Feas Stud. 2016;2(1):1–13. https://doi.org/10.1186/s40814-016-0061-3.
Palos G, Hutcheson K, Pytynia K, Schreiner C, Gilmore K, Chapman P, Bi W, Lewis-Patterson P, Goepfert R, Rodriguez M. Symptoms burden reported by head and neck cancer patients at their first survivorship clinic visit. J Clin Oncol. 2018;36(S15):e22090.
Mormer E, Bubb KJ, Alrawashdeh M, Cipkala-Gaffin JA. Hearing loss and communication among hospitalized older adults: prevalence and recognition. J Gerontol Nurs. 2020;46(6):34–42. https://doi.org/10.3928/00989134-20200316-03.
Baguley DM, Prayuenyong P. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemother Pharmacol. 2020;85(2):245–50.
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins A, Jemal A. Cancer treatment and survivorship statistics, 2014. Cancer J Clin. 2014;64(4):252–71. https://doi.org/10.3322/caac.21235.
Acknowledgements
We would like to acknowledge the survivors and their families who participate in the Head & Neck Cancer Survivorship Clinic at UPMC. They are generous with their time and communication to help us create the best possible care. We also appreciate all of the health care providers and support staff who make this clinical activity possible.
Funding
Beckwith Institute provided financial support.
Author information
Authors and Affiliations
Contributions
Lori Zitelli, Marci Nilsen, Elizabeth Mamula, and Jonas Johnson all participated in data acquisition, interpretation of data, writing, and revising of the manuscript. Catherine Palmer and Lori Zitelli participated in data analysis. Catherine Palmer and Grant Rauterkus participated in the data interpretation, writing, and revising of the manuscript. All authors had full access to all data and are accountable for study findings and reporting.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by University of Pittsburgh Human Research Protection Office Institutional Review Board (STUDY20090103).
Consent to participate
This study has IRB approval for a retrospective review and reporting of aggregate data.
Consent for publication
This study has IRB approval for a retrospective review and reporting of aggregate data.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Level of Evidence Descriptive Report (Level 4)
Rights and permissions
About this article
Cite this article
Zitelli, L., Palmer, C., Mamula, E. et al. Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic. J Cancer Surviv 17, 720–728 (2023). https://doi.org/10.1007/s11764-022-01198-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-022-01198-9